Antonio Cuadrado, Ana I. Rojo, and Albena Dinkova-Kostova were the organizers of this showcase meeting about NRF2, held in Madrid on April 2018. The aim of this meeting was to identify and promote strong and closely coordinated partnerships and collaborations between biopharmaceutical companies and expert academic laboratories with the aim of advancing the clinical development of NRF2 modulators in chronic diseases. The event gathered more than 50 researchers from 7 different countries and 9 companies. You can find more information here.
Defended thesis
Novel Nrf2 inducers with multitarget activities for the treatment of neurodegenerative diseases.
Click here to go to the thesis. Patrycja Michalska. International PhD Program. Date: 05/04/2019. Financiada por: FPU13/03737. Publications: https://pubmed.ncbi.nlm.nih.gov/?term=Patrycja+Michalska
nrf24ad
March 16, 2022
